'''Oltipraz''' is an organosulfur compound belonging to the [[dithiolethione]] class.<ref name="pmid19150646">{{cite journal |vauthors=Prince M, Li Y, Childers A, Itoh K, Yamamoto M, Kleiner HE | title = Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice | journal = Toxicol. Lett. | volume = 185 | issue = 3 | pages = 180–6 |date=March 2009 | pmid = 19150646 | pmc = 2676710 | doi = 10.1016/j.toxlet.2008.12.014 | url = }}</ref> It acts as a [[schistosomicide]] and has been shown in [[rodent]] models to inhibit the formation of cancers in the bladder, blood, colon, kidney, liver, lung, pancreas, stomach, and trachea, skin, and mammary tissue.<ref name="pmid15252150">{{cite journal |vauthors=Zhang Y, Gordon GB | title = A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway | journal = Mol. Cancer Ther. | volume = 3 | issue = 7 | pages = 885–93 |date=July 2004 | pmid = 15252150 | doi = | url = }}</ref><ref name="pmid15374950">{{cite journal  |vauthors=Iida K, Itoh K, Kumagai Y, etal |title=Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis |journal=Cancer Res. |volume=64 |issue=18 |pages=6424–31 |date=September 2004 |pmid=15374950 |doi=10.1158/0008-5472.CAN-04-1906 |url=http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=15374950}}</ref> Clinical trials of oltipraz have failed to demonstrate efficacy and have shown significant side effects, including neurotoxicity and gastrointestinal toxicity.<ref name="pmid15252150"/> Oltipraz has also been shown to generate [[superoxide radical]], which can be toxic.<ref name="pmid15680910">{{cite journal |vauthors=Velayutham M, Villamena FA, Fishbein JC, Zweier JL | title = Cancer chemopreventive oltipraz generates superoxide anion radical | journal = Arch. Biochem. Biophys. | volume = 435 | issue = 1 | pages = 83–8 |date=March 2005 | pmid = 15680910 | doi = 10.1016/j.abb.2004.11.028 | url = }}</ref>
